Frohlich Mark W 4
4 · RIGEL PHARMACEUTICALS INC · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Frohlich Mark W
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-06+12,000→ 12,000 totalExercise: $19.70Exp: 2035-03-06→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option shall vest in equal monthly installments over a period beginning on March 6, 2025 and ending on the date of the annual meeting at which the Reporting Person is first scheduled to be considered for election by the stockholders, subject to the Reporting Person's continuous service on the Company's Board of Directors.